Details
Stereochemistry | ACHIRAL |
Molecular Formula | C9H15NO4S |
Molecular Weight | 233.285 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC(=O)CCC(=O)SCCNC(C)=O
InChI
InChIKey=LCEITCPWQIJXGQ-UHFFFAOYSA-N
InChI=1S/C9H15NO4S/c1-7(11)10-5-6-15-9(13)4-3-8(12)14-2/h3-6H2,1-2H3,(H,10,11)
Molecular Formula | C9H15NO4S |
Molecular Weight | 233.285 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 19:55:17 GMT 2023
by
admin
on
Sat Dec 16 19:55:17 GMT 2023
|
Record UNII |
4GF65YYK2S
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
933323
Created by
admin on Sat Dec 16 19:55:17 GMT 2023 , Edited by admin on Sat Dec 16 19:55:17 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
866465-21-6
Created by
admin on Sat Dec 16 19:55:17 GMT 2023 , Edited by admin on Sat Dec 16 19:55:17 GMT 2023
|
PRIMARY | |||
|
4GF65YYK2S
Created by
admin on Sat Dec 16 19:55:17 GMT 2023 , Edited by admin on Sat Dec 16 19:55:17 GMT 2023
|
PRIMARY | |||
|
86075622
Created by
admin on Sat Dec 16 19:55:17 GMT 2023 , Edited by admin on Sat Dec 16 19:55:17 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE ACTIVE -> PRODRUG |
Developed for chronic oral treatment of Leigh syndrome, a severe primary mitochondrial disease that usually debuts at one to two years of age.
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
BRAIN/PLASMA RATIO | PHARMACOKINETIC |
|